International Stem Cell (ISCO) Q3 2018 Earnings Report

45 Followers

ISCO Q3 2018 EPS Results

Actual EPS-$0.10

Consensus EPS―

Beat/Miss―

One Year Ago EPS-$0.54

Actual Revenue$3.19M

Expected Revenue―

Beat/Miss―

YoY Revenue Growth―

QuarterQ3 2018

Date11/15/2018

TimeTBA

Conference CallThursday, November 15, 2018

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Mar 31, 2025	2024 (Q4)	- / -0.03	-0.027	-18.52% (>-0.01)
May 16, 2024	2024 (Q1)	- / -0.03	-0.004	-575.00% (-0.02)
Apr 09, 2024	2023 (Q4)	- / -0.06	-0.004	-1325.00% (-0.05)
May 18, 2023	2023 (Q1)	- / >-0.01	-0.001	-300.00% (>-0.01)
Apr 11, 2023	2022 (Q4)	- / <0.01	-0.001	400.00% (<+0.01)
May 17, 2022	2022 (Q1)	- / >-0.01	-0.08	98.75% (+0.08)
Mar 30, 2022	2021 (Q4)	- / -0.04	-0.096	54.17% (+0.05)
Nov 15, 2019	2019 (Q3)	- / 0.00	-0.1	―
May 17, 2019	2019 (Q1)	- / -	-0.14	―
May 17, 2019	2018 (Q4)	- / -0.12	-0.14	14.29% (+0.02)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed